|
ANP32B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.564500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.921700E-02 |
| Normal-vs-Stage2 |
1.005770E-01 |
| Normal-vs-Stage3 |
2.497400E-03 |
| Normal-vs-Stage4 |
4.271800E-02 |
| Stage1-vs-Stage2 |
9.868600E-01 |
| Stage1-vs-Stage3 |
1.957150E-01 |
| Stage1-vs-Stage4 |
7.756600E-01 |
| Stage2-vs-Stage3 |
4.138600E-01 |
| Stage2-vs-Stage4 |
8.376200E-01 |
| Stage3-vs-Stage4 |
5.492600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.722000E-03 |
| Normal-vs-AfricanAmerican |
1.600760E-01 |
| Normal-vs-Asian |
1.056250E-01 |
| Caucasian-vs-AfricanAmerican |
7.713200E-01 |
| Caucasian-vs-Asian |
5.991400E-01 |
| AfricanAmerican-vs-Asian |
9.339800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.621590E-02 |
| Normal-vs-Female |
7.882100E-03 |
| Male-vs-Female |
8.568200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.056200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.729700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.808300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.442800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.267600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.620200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.123850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.680100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.196200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.757770E-01 |
| Classical-VS-Follicular |
1.358580E-01 |
| Classical-VS-Other |
9.019800E-01 |
| Classical-VS-Normal |
3.523600E-02 |
| Tall-VS-Follicular |
9.115200E-01 |
| Tall-VS-Other |
6.155400E-01 |
| Tall-VS-Normal |
6.457500E-03 |
| Follicular-VS-Other |
7.130800E-01 |
| Follicular-VS-Normal |
4.259300E-03 |
| Other-VS-Normal |
4.972600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.855300E-03 |
| Normal-vs-N1 |
9.61550000000422E-05 |
| N0-vs-N1 |
2.847900E-02 |
|
|
